Back-to-back papers published online this week in Nature Genetics reveal important new details about the genetic variability of the malaria parasite and provide new clues for how it causes disease.
An international research team announced today the completion of a genome-wide map that charts the genetic variability of the human malaria parasite Plasmodium falciparum.
Researchers at Universit? de Montr?al, working with teams at Massachusetts General Hospital and Johns Hopkins University, have made a major breakthrough in understanding an essential aspect of the immune system.
While investigating a fungus known to cause an infection in people with AIDS, two grantees of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), unexpectedly discovered a potential strategy for treating metastatic melanoma, one of the deadliest forms of skin cancer.
Sea urchins are small and spiny, they have no eyes and they eat kelp and algae. Still, the sea creature?s genome is remarkably similar to humans? and may hold the key to preventing and curing several human diseases, according to a University of Central Florida researcher and several colleagues.
Researchers in the Greene Infectious Disease Laboratory at Columbia University’s Mailman School of Public Health and their colleagues in the WHO Global Laboratory Network have developed a new tool for pathogen surveillance and discovery — the GreeneChip System. The GreeneChip is the first tool to provide comprehensive, differential diagnosis of infectious diseases, including those caused by viruses, bacteria, fungi or parasites.
Results from one of the largest HIV/AIDS treatment trials ever conducted show that a specific strategy of interrupting antiretroviral therapy more than doubles the risk of AIDS or death from any cause. In the study, the investigators used two predetermined levels of CD4+ T cells, the primary immune cell targeted by HIV, to guide them in respectively suspending or restarting the study participants on antiretroviral therapy.
Novartis unveiled today new data on its promising pipeline amid plans for multiple new product approvals and launches over the next two years. Many of these anticipated approvals are for potentially best-in-class medicines that would advance treatment standards for patients with hypertension, diabetes, cancer and other diseases.
It sounds like the stuff of a campy ’50s horror movie (“It Came from the Ice!”), but a Bowling Green State University biologist believes it’s a very real possibility.
Pope Benedict XVI is greatly concerned by HIV pandemic and considering about use of condoms to fight against HIV / AIDS, Vatican sources confirms. The Vatican’s office for health care has concluded a study on the use of condoms in the fight against AIDS, and a long-awaited report on it is now being examined by the Vatican’s doctrinal watchdog, a senior cardinal said.